Synthesis of erythrodiol C-ring derivatives and their activity against Chlamydia trachomatis. 2021

Oxana Kazakova, and Liudmila Rubanik, and Alexander Lobov, and Nikolai Poleshchuk, and Irina Baikova, and Yuliya Kapustina, and Anastasiya Petrova, and Tatyana Korzun, and Tatyana Lopatina, and Alexandra Fedorova, and Tatyana Rybalova, and Dmitri Polovianenko, and Marius Mioc, and Codruța Șoica
Ufa Institute of Chemistry of the Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa 450054, Russian Federation. Electronic address: obf@anrb.ru.

To develop new potential agents against Chlamydia trachomatis among oleanane type triterpenoids the synthesis, spectral and X-ray analysis as well as antimicrobial screening of C-12 oxygen and nitrogen derivatives of erythrodiol is presented. The reduction of methyl 3β-acetoxy-12-oxo-oleanoate with LiAlH4 led to isomeric erythrodiol 12β- and 12α-hydroxy-derivatives, their stereochemistry with respect to the position of hydroxyl-group at C-12 was determined based on the multiplets splitting patterns, the magnitude of the spin-spin interaction, and NOESY interactions. Methyl 3β-acetoxy-12-oxo-oleanoate was transformed to 12E-hydroxyimino- and 12E-methoxyimino-derivatives by the interaction with NH2OH∙HCl or CH3ONH2∙HCl, respectively. By Beckmann rearrangement with SOCl2 in dioxane 12E-oxime was converted to C-lactame and its following reduction with LiAlH4 in THF or dioxane led to erythrodiol C-azepanone or C-azepane derivatives. The structure 3-O,12-N-bis-acetyl-derivative of C-azepane-erythrodiol was confirmed by the single crystal X-ray analysis. Erythrodiol 12β-hydroxy- and C-azepane derivatives were found to be lead compounds with significant activity against C. trachomatis with MIC 1.56 and 3.125 μg/mL. Molecular docking was employed to suggest potential binding interaction, the tested compounds are likely to act as Cdu1 protein inhibitors while 12β-hydroxy-erythrodiol exhibited the highest affinity towards this respective target protein. These results indicated that C-ring oxygen and nitrogen erythrodiol derivatives might be considered for further research in the design of antibacterial agents against Chlamydia trachomatis.

UI MeSH Term Description Entries
D002692 Chlamydia trachomatis Type species of CHLAMYDIA causing a variety of ocular and urogenital diseases.

Related Publications

Oxana Kazakova, and Liudmila Rubanik, and Alexander Lobov, and Nikolai Poleshchuk, and Irina Baikova, and Yuliya Kapustina, and Anastasiya Petrova, and Tatyana Korzun, and Tatyana Lopatina, and Alexandra Fedorova, and Tatyana Rybalova, and Dmitri Polovianenko, and Marius Mioc, and Codruța Șoica
January 2021, BioMed research international,
Oxana Kazakova, and Liudmila Rubanik, and Alexander Lobov, and Nikolai Poleshchuk, and Irina Baikova, and Yuliya Kapustina, and Anastasiya Petrova, and Tatyana Korzun, and Tatyana Lopatina, and Alexandra Fedorova, and Tatyana Rybalova, and Dmitri Polovianenko, and Marius Mioc, and Codruța Șoica
January 1987, Drugs,
Oxana Kazakova, and Liudmila Rubanik, and Alexander Lobov, and Nikolai Poleshchuk, and Irina Baikova, and Yuliya Kapustina, and Anastasiya Petrova, and Tatyana Korzun, and Tatyana Lopatina, and Alexandra Fedorova, and Tatyana Rybalova, and Dmitri Polovianenko, and Marius Mioc, and Codruța Șoica
January 2011, Bioorganicheskaia khimiia,
Oxana Kazakova, and Liudmila Rubanik, and Alexander Lobov, and Nikolai Poleshchuk, and Irina Baikova, and Yuliya Kapustina, and Anastasiya Petrova, and Tatyana Korzun, and Tatyana Lopatina, and Alexandra Fedorova, and Tatyana Rybalova, and Dmitri Polovianenko, and Marius Mioc, and Codruța Șoica
January 1988, Sexually transmitted diseases,
Oxana Kazakova, and Liudmila Rubanik, and Alexander Lobov, and Nikolai Poleshchuk, and Irina Baikova, and Yuliya Kapustina, and Anastasiya Petrova, and Tatyana Korzun, and Tatyana Lopatina, and Alexandra Fedorova, and Tatyana Rybalova, and Dmitri Polovianenko, and Marius Mioc, and Codruța Șoica
October 1999, The Journal of antimicrobial chemotherapy,
Oxana Kazakova, and Liudmila Rubanik, and Alexander Lobov, and Nikolai Poleshchuk, and Irina Baikova, and Yuliya Kapustina, and Anastasiya Petrova, and Tatyana Korzun, and Tatyana Lopatina, and Alexandra Fedorova, and Tatyana Rybalova, and Dmitri Polovianenko, and Marius Mioc, and Codruța Șoica
January 1991, Journal of chemotherapy (Florence, Italy),
Oxana Kazakova, and Liudmila Rubanik, and Alexander Lobov, and Nikolai Poleshchuk, and Irina Baikova, and Yuliya Kapustina, and Anastasiya Petrova, and Tatyana Korzun, and Tatyana Lopatina, and Alexandra Fedorova, and Tatyana Rybalova, and Dmitri Polovianenko, and Marius Mioc, and Codruța Șoica
January 1990, The Journal of antimicrobial chemotherapy,
Oxana Kazakova, and Liudmila Rubanik, and Alexander Lobov, and Nikolai Poleshchuk, and Irina Baikova, and Yuliya Kapustina, and Anastasiya Petrova, and Tatyana Korzun, and Tatyana Lopatina, and Alexandra Fedorova, and Tatyana Rybalova, and Dmitri Polovianenko, and Marius Mioc, and Codruța Șoica
August 1989, Journal of chemotherapy (Florence, Italy),
Oxana Kazakova, and Liudmila Rubanik, and Alexander Lobov, and Nikolai Poleshchuk, and Irina Baikova, and Yuliya Kapustina, and Anastasiya Petrova, and Tatyana Korzun, and Tatyana Lopatina, and Alexandra Fedorova, and Tatyana Rybalova, and Dmitri Polovianenko, and Marius Mioc, and Codruța Șoica
December 1980, Antimicrobial agents and chemotherapy,
Oxana Kazakova, and Liudmila Rubanik, and Alexander Lobov, and Nikolai Poleshchuk, and Irina Baikova, and Yuliya Kapustina, and Anastasiya Petrova, and Tatyana Korzun, and Tatyana Lopatina, and Alexandra Fedorova, and Tatyana Rybalova, and Dmitri Polovianenko, and Marius Mioc, and Codruța Șoica
October 1988, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!